In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wellness Research Round-up: Probiotics, Vitamin D Supps, Haskap Berry Extract and Caffeine For Combat Sports

Executive Summary

Summary of scientific research on dietary supplementation and supplement ingredients, including two studies on probiotics which reached very different conclusions, and one on the benefits of Vitamin D supplementation for cognition. Studies on haskap berry extract for back pain and on caffeine supplementation for combat sports performance are also explored.

You may also be interested in...



Glucosamine Supps For Heart Health? Large UK Biobank Study Says Yes

A large-population UK study published in the British Medical Journal has found that habitual use of glucosamine supplements may reduce the risk of cardiovascular disease events, such as 

Vegan Trend Propelling Growth of UK Dietary Supplements Market

Vegans and vegetarians looking to supplement their diet with calcium and iron helped boost overall sales of VMS products in the UK in 2018, according to data from Mintel. Total VMS sales reached £442m in 2018, with the market forecast to grow by 8% over the next five years.

OptiBiotix Health Strikes Deal To Take CholBiome Probiotic Into Russia And Kazakhstan

British probiotic specialist OptiBiotix Health has struck a three-year distribution deal for its CholBiome supplement in Russia and Kazakhstan.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel